Baird Downgrades Edwards Lifesciences (EW) to Neutral
Baird analyst David Rescott downgraded Edwards Lifesciences (NYSE: EW) from Outperform ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
